Iptacopan Hydrochloride Patent Expiration
Iptacopan Hydrochloride was first introduced by Novartis Pharmaceuticals Corp
Iptacopan Hydrochloride Patents
Given below is the list of patents protecting Iptacopan Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fabhalta | US11951101 | Methods of using factor B inhibitors | Jul 15, 2041 | Novartis |
| Fabhalta | US11603363 | Crystalline form of LNP023 | May 25, 2041 | Novartis |
| Fabhalta | US11723901 | Uses of piperidinyl-indole derivatives | Aug 30, 2038 | Novartis |
| Fabhalta | US10093663 | Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof | Jul 14, 2034 | Novartis |
| Fabhalta | US9682968 | Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof | Jul 14, 2034 | Novartis |
Iptacopan Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List